Keyphrases
Cannabidiol
100%
Placebo-controlled Trial
100%
Neuropathic Pain
100%
Cannabis-based Medicine
100%
Spasticity
100%
Tetrahydrocannabinol
88%
Spinal Cord Injury
44%
Multiple Sclerosis
44%
Placebo
22%
Pain Intensity
22%
COVID-19 Challenges
11%
Δ9-tetrahydrocannabinol (Δ9-THC)
11%
EudraCT
11%
Maximum Tolerated Dose
11%
Quality of Life
11%
Patient Global Impression of Change
11%
Treatment Duration
11%
No Significant Difference
11%
Denmark
11%
Four-arm
11%
Placebo Treatment
11%
Central Neuropathic Pain
11%
Parallel Trials
11%
Active Treatment
11%
Life Changes
11%
Recruitment Challenges
11%
EU Clinical Trials Register
11%
Numerical Rating Scale
11%
Medicine and Dentistry
Spasticity
100%
Neuropathic Pain
100%
Medicine
100%
Placebo
100%
Cannabis
100%
Nabiximols
71%
Tetrahydrocannabinol
57%
Cannabidiol
57%
Spinal Cord Injury
57%
Multiple Sclerosis
57%
Arm
14%
Effects of Cannabis
14%
COVID-19
14%
Dronabinol
14%
Quality of Life
14%
Treatment Duration
14%
Clinical Trial
14%
Numeric Rating Scale
14%
Pharmacology, Toxicology and Pharmaceutical Science
Neuropathic Pain
100%
Cannabis
100%
Placebo
100%
Spasticity
100%
Nabiximols
71%
Cannabidiol
57%
Multiple Sclerosis
57%
Tetrahydrocannabinol
57%
Spinal Cord Injury
57%
Dronabinol
14%
Clinical Trial
14%